Hyperlipoproteinemia Type 3: The Forgotten Phenotype

Apolipoprotein E mutations: a comparison between lipoprotein glomerulopathy and type III hyperlipoproteinemia

(2014) Akira Matsunaga et al.   Clinical and Experimental Nephrology

Prevalence of the Apolipoprotein E Arg145Cys Dyslipidemia At-Risk Polymorphism in African-Derived Populations

(2013) Maen D. Abou Ziki et al.   AMERICAN JOURNAL OF CARDIOLOGY

Hepatic Remnant Lipoprotein Clearance by Heparan Sulfate Proteoglycans and Low-Density Lipoprotein Receptors Depend on Dietary Conditions in Mice

(2013) Erin M. Foley et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Apolipoprotein A-IV Expression in Mouse Liver Enhances Triglyceride Secretion and Reduces Hepatic Lipid Content by Promoting Very Low Density Lipoprotein Particle Expansion

(2013) Melissa A. VerHague et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Resequencing the APOE gene reveals that rare mutations are not significant contributory factors in the development of type III hyperlipidemia

(2013) David Evans et al.   Journal of Clinical Lipidology

Triglyceride-cholesterol imbalance across lipoprotein subclasses predicts diabetic kidney disease and mortality in type 1 diabetes: the FinnDiane Study

(2013) V.-P. Mäkinen et al.   JOURNAL OF INTERNAL MEDICINE

Docosahexaenoic acid impairs the maturation of very low density lipoproteins in rat hepatic cells

(2013) Vatsala Maitin et al.   JOURNAL OF LIPID RESEARCH

Insulin-Stimulated Degradation of Apolipoprotein B100: Roles of Class II Phosphatidylinositol-3-Kinase and Autophagy

(2013) Ursula Andreo et al.   PLoS One

Postprandial lipoproteins and the molecular regulation of vascular homeostasis

(2013) Kathleen M. Botham et al.   PROGRESS IN LIPID RESEARCH

Apolipoprotein E in VLDL and LDL With Apolipoprotein C‐III is Associated With a Lower Risk of Coronary Heart Disease

(2013) Carlos O. Mendivil et al.   Journal of the American Heart Association

Selective Hepatic Insulin Resistance, VLDL Overproduction, and Hypertriglyceridemia

(2012) Janet D. Sparks et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Apolipoprotein B Secretory Regulation by Degradation

(2012) Sven-Olof Olofsson et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Apolipoprotein A–V modulates multiple atherogenic mechanisms in a mouse model of disturbed clearance of triglyceride-rich lipoproteins

(2012) Itamar Grosskopf et al.   ATHEROSCLEROSIS

Apolipoprotein E gene mutations in subjects with mixed hyperlipidemia and a clinical diagnosis of familial combined hyperlipidemia

(2012) María Solanas-Barca et al.   ATHEROSCLEROSIS

Hepatic lipase activity is decreased in Japanese patients with type III hyperlipoproteinemia

(2012) Toshio Murase et al.   CLINICA CHIMICA ACTA

Microsome-associated lumenal lipid droplets in the regulation of lipoprotein secretion

(2012) Zemin Yao et al.   CURRENT OPINION IN LIPIDOLOGY

Disappearance of Angina Pectoris by Lipid-Lowering in Type III Hyperlipoproteinemia

(2011) Eun Jeung Cho et al.   AMERICAN JOURNAL OF CARDIOLOGY

Dual Metabolic Defects Are Required to Produce Hypertriglyceridemia in Obese Subjects

(2011) Marja-Riitta Taskinen et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

An Increased Burden of Common and Rare Lipid-Associated Risk Alleles Contributes to the Phenotypic Spectrum of Hypertriglyceridemia

(2011) Christopher T. Johansen et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Low-Density Lipoproteins Containing Apolipoprotein C-III and the Risk of Coronary Heart Disease

(2011) Carlos O. Mendivil et al.   CIRCULATION

Impact of bezafibrate and atorvastatin on lipoprotein subclass in patients with type III hyperlipoproteinemia: Result from a crossover study

(2011) Masa-aki Kawashiri et al.   CLINICA CHIMICA ACTA

Missense Mutation inAPOC3within the C-terminal Lipid Binding Domain of Human ApoC-III Results in Impaired Assembly and Secretion of Triacylglycerol-rich Very Low Density Lipoproteins

(2011) Wen Qin et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Complexities of plasma apolipoprotein C-III metabolism: Fig. 1.

(2011) Frank M. Sacks et al.   JOURNAL OF LIPID RESEARCH

Transcriptional Activation of Apolipoprotein CIII Expression by Glucose May Contribute to Diabetic Dyslipidemia

(2010) Sandrine Caron et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Rare variants in the lipoprotein lipase (LPL) gene are common in hypertriglyceridemia but rare in Type III hyperlipidemia

(2010) D. Evans et al.   ATHEROSCLEROSIS

Regulation of Hepatic ApoC3 Expression by PGC-1β Mediates Hypolipidemic Effect of Nicotinic Acid

(2010) Carlos Hernandez et al.   Cell Metabolism

Apolipoprotein C-III and the Metabolic Basis for Hypertriglyceridemia and the Dense Low-Density Lipoprotein Phenotype

(2010) Chunyu Zheng et al.   CIRCULATION

Seven Direct Methods for Measuring HDL and LDL Cholesterol Compared with Ultracentrifugation Reference Measurement Procedures

(2010) W. G. Miller et al.   CLINICAL CHEMISTRY

Polymorphism of apolipoprotein E

(2010) G. Utermann et al.   CLINICAL GENETICS

Type 2 diabetes in mice induces hepatic overexpression of sulfatase 2, a novel factor that suppresses uptake of remnant lipoproteins

(2010) Keyang Chen et al.   HEPATOLOGY

Effect of apolipoprotein E genotype on apolipoprotein B-100 metabolism in normolipidemic and hyperlipidemic subjects

(2010) Esther M. M. Ooi et al.   JOURNAL OF LIPID RESEARCH

Biogenesis of apolipoprotein A-V and its impact on VLDL triglyceride secretion

(2010) Anna M. Blade et al.   JOURNAL OF LIPID RESEARCH

Inactivation of the LRP1 Intracellular NPxYxxL Motif in LDLR-Deficient Mice Enhances Postprandial Dyslipidemia and Atherosclerosis

(2009) Philip L.S.M. Gordts et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Metabolism of Very-Low-Density Lipoprotein and Low-Density Lipoprotein Containing Apolipoprotein C-III and Not Other Small Apolipoproteins

(2009) Carlos O. Mendivil et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Altered composition of triglyceride-rich lipoproteins and coronary artery disease in a large case–control study

(2009) Paul N. Hopkins et al.   ATHEROSCLEROSIS

Scavenger receptor, Class B, Type I provides an alternative means for β-VLDL uptake independent of the LDL receptor in tissue culture

(2009) Clemens Röhrl et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS

Limitations of Automated Remnant Lipoprotein Cholesterol Assay for Diagnostic Use

(2009) E. J. Schaefer   CLINICAL CHEMISTRY

Heparan Sulfate 2-O-Sulfotransferase Is Required for Triglyceride-rich Lipoprotein Clearance

(2009) Kristin I. Stanford et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Overproduction of Very Low–Density Lipoproteins Is the Hallmark of the Dyslipidemia in the Metabolic Syndrome

(2008) Martin Adiels et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Distinct patterns of heparin affinity chromatography VLDL1 and VLDL2 subfractions in the different dyslipidaemias

(2008) L. Duvillard et al.   ATHEROSCLEROSIS

Lipid droplets as dynamic organelles connecting storage and efflux of lipids

(2008) Sven-Olof Olofsson et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS

Apolipoprotein CIII Links Hyperlipidemia With Vascular Endothelial Cell Dysfunction

(2008) Akio Kawakami et al.   CIRCULATION

Toll-Like Receptor 2 Mediates Apolipoprotein CIII–Induced Monocyte Activation: Retracted

(2008) Akio Kawakami et al.   CIRCULATION RESEARCH

Effects of 20 mg rosuvastatin on VLDL1-, VLDL2-, IDL- and LDL-ApoB kinetics in type 2 diabetes

(2008) B. Vergès et al.   DIABETOLOGIA

The expression of type III hyperlipoproteinemia: involvement of lipolysis genes

(2008) Peter Henneman et al.   EUROPEAN JOURNAL OF HUMAN GENETICS

The hepatic uptake of VLDL inlrp−ldlr−/−vldlr−/−mice is regulated by LPL activity and involves proteoglycans and SR-BI

(2008) Lihui Hu et al.   JOURNAL OF LIPID RESEARCH